28-Jan-2026
No headlines found.
No press releases found.
No news found.
The Market Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
Vaneck Pharmaceutical ETF trades on the NASDAQ stock market under the symbol PPH.
As of January 28, 2026, PPH stock price declined to $105.39 with 549,011 million shares trading.
PPH has a beta of 0.45, meaning it tends to be less sensitive to market movements. PPH has a correlation of 0.14 to the broad based SPY ETF.
PPH has a market cap of $1.17 billion. This is considered a Small Cap stock.
In the last 3 years, PPH traded as high as $108.26 and as low as $73.40.
PPH has outperformed the market in the last year with a return of +19.4%, while the SPY ETF gained +17.2%. In the last 3 month period, PPH beat the market returning +14.2%, while SPY returned +1.8%. However, in the most recent 2 weeks PPH has underperformed the stock market by returning -0.1%, while SPY returned +0.2%.
PPH support price is $106.27 and resistance is $108.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPH shares will trade within this expected range on the day.
